146 related articles for article (PubMed ID: 11479401)
1. Fecal calprotectin: a significant step in the noninvasive assessment of intestinal inflammation.
Bjarnason I; Sherwood R
J Pediatr Gastroenterol Nutr; 2001 Jul; 33(1):11-3. PubMed ID: 11479401
[No Abstract] [Full Text] [Related]
2. Age-dependent variations in fecal calprotectin concentrations in children.
Rugtveit J; Fagerhol MK
J Pediatr Gastroenterol Nutr; 2002 Mar; 34(3):323-4; author reply 324-5. PubMed ID: 11964964
[No Abstract] [Full Text] [Related]
3. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease.
Tibble JA; Sigthorsson G; Foster R; Forgacs I; Bjarnason I
Gastroenterology; 2002 Aug; 123(2):450-60. PubMed ID: 12145798
[TBL] [Abstract][Full Text] [Related]
4. Is fecal calprotectin the next standard in inflammatory bowel disease activity tests?
Alic M
Am J Gastroenterol; 1999 Nov; 94(11):3370-1. PubMed ID: 10566749
[No Abstract] [Full Text] [Related]
5. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease.
Bunn SK; Bisset WM; Main MJ; Golden BE
J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):171-7. PubMed ID: 11321388
[TBL] [Abstract][Full Text] [Related]
6. Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy.
Limburg PJ; Ahlquist DA; Sandborn WJ; Mahoney DW; Devens ME; Harrington JJ; Zinsmeister AR
Am J Gastroenterol; 2000 Oct; 95(10):2831-7. PubMed ID: 11051356
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of NSAID enteropathy as shown by a simple faecal test.
Tibble JA; Sigthorsson G; Foster R; Scott D; Fagerhol MK; Roseth A; Bjarnason I
Gut; 1999 Sep; 45(3):362-6. PubMed ID: 10446103
[TBL] [Abstract][Full Text] [Related]
8. Faecal calprotectin levels and colorectal neoplasia.
Brydon WG; Campbell SS; Anderson NA; Wilson RG; Ghosh S
Gut; 2001 Apr; 48(4):579-80. PubMed ID: 11288736
[No Abstract] [Full Text] [Related]
9. Chronic diarrhea: to scope or not to scope?
Achkar JP
Inflamm Bowel Dis; 2001 Aug; 7(3):276-7. PubMed ID: 11515856
[No Abstract] [Full Text] [Related]
10. Improved assay for fecal calprotectin.
Tøn H; Brandsnes ; Dale S; Holtlund J; Skuibina E; Schjønsby H; Johne B
Clin Chim Acta; 2000 Feb; 292(1-2):41-54. PubMed ID: 10686275
[TBL] [Abstract][Full Text] [Related]
11. Assessment of ileal pouch inflammation by single-stool calprotectin assay.
Thomas P; Rihani H; Røseth A; Sigthorsson G; Price A; Nicholls RJ; Bjarnason I
Dis Colon Rectum; 2000 Feb; 43(2):214-20. PubMed ID: 10696896
[TBL] [Abstract][Full Text] [Related]
12. [Fecal calprotectin].
Rodrigo L
Rev Esp Enferm Dig; 2007 Dec; 99(12):683-8. PubMed ID: 18290690
[No Abstract] [Full Text] [Related]
13. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease.
Bunn SK; Bisset WM; Main MJ; Gray ES; Olson S; Golden BE
J Pediatr Gastroenterol Nutr; 2001 Jul; 33(1):14-22. PubMed ID: 11479402
[TBL] [Abstract][Full Text] [Related]
14. Biological variability of fecal calprotectin in patients referred for colonoscopy without colonic inflammation or neoplasm.
Husebye E; Tøn H; Johne B
Am J Gastroenterol; 2001 Sep; 96(9):2683-7. PubMed ID: 11569695
[TBL] [Abstract][Full Text] [Related]
15. Screening of first degree relatives of patients operated for colorectal cancer: evaluation of fecal calprotectin vs. hemoccult II.
Kristinsson J; Nygaard K; Aadland E; Barstad S; Sauar J; Hofstad B; Stray N; Stallemo A; Haug B; Ugstad M; Tøn H; Fuglerud P
Digestion; 2001; 64(2):104-10. PubMed ID: 11684824
[TBL] [Abstract][Full Text] [Related]
16. Fecal excretion of calprotectin in colorectal cancer: relationship to tumor characteristics.
Kristinsson J; Armbruster CH; Ugstad M; Kriwanek S; Nygaard K; Tøn H; Fuglerud P
Scand J Gastroenterol; 2001 Feb; 36(2):202-7. PubMed ID: 11252414
[TBL] [Abstract][Full Text] [Related]
17. [Fecal calprotectin in complex diagnostics of intestinal diseases].
Livzan MA; Dolgikh TI; Lialiukova EA
Eksp Klin Gastroenterol; 2013; (12):83-6. PubMed ID: 24933995
[TBL] [Abstract][Full Text] [Related]
18. Elevated fecal calprotectin and lactoferrin associated with small intestinal lesions in patients with Behçet disease.
Hayashida M; Miyoshi J; Mitsui T; Miura M; Saito D; Sakuraba A; Kawashima S; Ikegaya N; Fukuoka K; Karube M; Komagata Y; Kaname S; Okada AA; Fujimori S; Matsuura M; Hisamatsu T
J Gastroenterol Hepatol; 2020 Aug; 35(8):1340-1346. PubMed ID: 31999379
[TBL] [Abstract][Full Text] [Related]
19. Elevated fecal M2-pyruvate kinase in children with cystic fibrosis: a clue to the increased risk of intestinal malignancy in adulthood?
Pang T; Leach ST; Katz T; Jaffe A; Day AS; Ooi CY
J Gastroenterol Hepatol; 2015 May; 30(5):866-71. PubMed ID: 25376228
[TBL] [Abstract][Full Text] [Related]
20. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method.
Johne B; Kronborg O; Tøn HI; Kristinsson J; Fuglerud P
Scand J Gastroenterol; 2001 Mar; 36(3):291-6. PubMed ID: 11305517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
